Review article: Evidence-based dietary advice for patients with inflammatory bowel disease

Alimentary Pharmacology and Therapeutics

Volumn 38, Issue 10, 2013, Pages 1156-1171

  Richman, E ^a   Rhodes, J M ^b  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CALCIUM; CORTICOSTEROID; CURCUMIN; DETERGENT; DOCOSAHEXAENOIC ACID; EMULSIFYING AGENT; FRUCTOSE OLIGOSACCHARIDE; GALACTOSE OLIGOSACCHARIDE; ICOSAPENTAENOIC ACID; LACTOSE; MALTODEXTRIN; NANOPARTICLE; OLIVE OIL; OMEGA 3 FATTY ACID; PLACEBO; PREBIOTIC AGENT; TITANIUM DIOXIDE; VITAMIN D;

ADJUVANT THERAPY; CALORIC INTAKE; CARBOHYDRATE DIET; CROHN DISEASE; DAIRY PRODUCT; DIET RESTRICTION; DIET SUPPLEMENTATION; DIET THERAPY; DIETARY FIBER; DIETARY INTAKE; ENTERIC FEEDING; ENTERITIS; EVIDENCE BASED PRACTICE; FAT INTAKE; GLUCOSE INTAKE; GLUTEN FREE DIET; HUMAN; INCIDENCE; INTESTINE FLORA; LOW FAT DIET; OXIDATIVE STRESS; PLANT FIBER; PRIORITY JOURNAL; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; REVIEW; SUGAR INTAKE; SYSTEMATIC REVIEW; TOTAL PARENTERAL NUTRITION; ULCERATIVE COLITIS; VITAMIN SUPPLEMENTATION;

ANIMALS; COLITIS, ULCERATIVE; CROHN DISEASE; DIET; DIETARY SUPPLEMENTS; ENTERAL NUTRITION; EVIDENCE-BASED MEDICINE; HUMANS; RECURRENCE; VITAMIN D;

EID: 84885951276     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12500     Document Type: Review

References (101)

1. Halfvarson J,. Genetics in twins with Crohn's disease: less pronounced than previously believed? Inflamm Bowel Dis 2011; 17: 6-12.
2. Lashner BA, Evans AA, Kirsner JB, Hanauer SB,. Prevalence and incidence of inflammatory bowel disease in family members. Gastroenterology 1986; 91: 1396-400.
3. Wong SH, Ng SC,. What can we learn from inflammatory bowel disease in developing countries? Curr Gastroenterol Rep 2013; 15: 313.
4. Fell JM,. Control of systemic and local inflammation with transforming growth factor beta containing formulas. J Parenter Enteral Nutr 2005; 29: S126-8.
5. Nightingale J, Woodward JM,. Guidelines for the management of patients with a short bowel. Gut 2006; 55 (Suppl. 4): iv1-12.
6. Scrimgeour AG, Condlin ML,. Zinc and micronutrient combinations to combat gastrointestinal inflammation. Curr Opin Clin Nutr Metab Care 2009; 12: 653-60.
7. Ostro MJ, Greenberg GR, Jeejeebhoy KN,. Total parenteral nutrition and complete bowel rest in the management of Crohn's disease. J Parenter Enteral Nutr 1985; 9: 280-7.
8. Dickinson RJ, Ashton MG, Axon AT, Smith RC, Yeung CK, Hill GL,. Controlled trial of intravenous hyperalimentation and total bowel rest as an adjunct to the routine therapy of acute colitis. Gastroenterology 1980; 79: 1199-204.
9. McIntyre PB, Powell-Tuck J, Wood SR, et al,. Controlled trial of bowel rest in the treatment of severe acute colitis. Gut 1986; 27: 481-5.
10. Zachos M, Tondeur M, Griffiths AM,. Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database Syst Rev 2007; 1: CD000542.
11. Akobeng AK, Thomas AG,. Enteral nutrition for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev 2007; 3: CD005984.
12. Yamamoto T, Nakahigashi M, Umegae S, Matsumoto K,. Enteral nutrition for the maintenance of remission in Crohn's disease: a systematic review. Eur J Gastroenterol Hepatol 2010; 22: 1-8.
13. Takagi S, Utsunomiya K, Kuriyama S, et al,. Effectiveness of an 'half elemental diet' as maintenance therapy for Crohn's disease: a randomized-controlled trial. Aliment Pharmacol Ther 2006; 24: 1333-40.
14. Fell JM, Paintin M, Arnaud-Battandier F, et al,. Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease. Aliment Pharmacol Ther 2000; 14: 281-9.
15. Newby EA, Sawczenko A, Thomas AG, Wilson D,. Interventions for growth failure in childhood Crohn's disease. Cochrane Database Syst Rev 2005; 3: CD003873.
16. Day AS, Whitten KE, Sidler M, Lemberg DA,. Systematic review: nutritional therapy in paediatric Crohn's disease. Aliment Pharmacol Ther 2008; 27: 293-307.
17. Gerasimidis K, Talwar D, Duncan A, et al,. Impact of exclusive enteral nutrition on body composition and circulating micronutrients in plasma and erythrocytes of children with active Crohn's disease. Inflamm Bowel Dis 2012; 18: 1672-81.
18. Cameron FL, Gerasimidis K, Papangelou A, et al,. Clinical progress in the two years following a course of exclusive enteral nutrition in 109 paediatric patients with Crohn's disease. Aliment Pharmacol Ther 2013; 37: 622-9.
19. Grover Z, Muir R, Lewindon P,. Exclusive enteral nutrition induces early clinical, mucosal and transmural remission in paediatric Crohn's disease. J Gastroenterol 2013 [Epub ahead of print].
20. Whitten KE, Rogers P, Ooi CY, Day AS,. International survey of enteral nutrition protocols used in children with Crohn's disease. J Dig Dis 2012; 13: 107-12.
21. Raouf AH, Hildrey V, Daniel J, et al,. Enteral feeding as sole treatment for Crohn's disease: controlled trial of whole protein v amino acid based feed and a case study of dietary challenge. Gut 1991; 32: 702-7.
22. Rubio A, Pigneur B, Garnier-Lengliné H, et al,. The efficacy of exclusive nutritional therapy in paediatric Crohn's disease, comparing fractionated oral vs. continuous enteral feeding. Aliment Pharmacol Ther 2011; 33: 1332-9.
23. Afzal NA, Davies S, Paintin M, et al,. Colonic Crohn's disease in children does not respond as well to treatment with enteral nutrition if the ileum is not involved. Dig Dis Sci 2005; 50: 1471-4.
24. Middleton SJ, Rucker JT, Kirby GA, Riordan AM, Hunter JO,. Long-chain triglycerides reduce the efficacy of enteral feeds in patients with active Crohn's disease. Clin Nutr 1995; 14: 229-36.
25. Turner D, Shah PS, Steinhart AH, Zlotkin S, Griffiths AM,. Maintenance of remission in inflammatory bowel disease using omega-3 fatty acids (fish oil): a systematic review and meta-analyses. Inflamm Bowel Dis 2011; 17: 336-45.
26. Cabré E, Mañosa M, Gassull MA,. Omega-3 fatty acids and inflammatory bowel diseases-a systematic review. Br J Nutr 2012; 107 (Suppl. 2): S240-52.
27. Kumar S, Ahuja V, Sankar MJ, Kumar A, Moss AC,. Curcumin for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 2012; 10: CD008424.
28. Ritchie JK, Wadsworth J, Lennard-Jones JE, Rogers E,. Controlled multicentre therapeutic trial of an unrefined carbohydrate rich diet in Crohn's disease Br Med J 1987; 295: 517-20.
29. Brandes JW, Lorenz-Meyer H,. Sugar free diet: a new perspective in the treatment of Crohn's disease? Randomised control study Z Gastroenterol 1981; 19: 1-12.
30. Lomer MC, Thompson RP, Powell JJ,. Fine and ultra fine particles of the diet: influence on the mucosal immune response and association with Crohn's disease. Proc Nutr Soc 2002; 61: 123-30.
31. Butler M, Boyle JJ, Powell JJ, Playford RJ, Ghosh S,. Dietary microparticles implicated in Crohn's disease can impair macrophage phagocytic activity and act as adjuvants in the presence of bacterial stimuli. Inflamm Res 2007; 56: 353-61.
32. Lomer MC, Harvey RS, Evans SM, Thompson RP, Powell JJ,. Efficacy and tolerability of a low microparticle diet in a double blind, randomized, pilot study in Crohn's disease. Eur J Gastroenterol Hepatol 2001; 13: 101-6.
33. Lomer MC, Grainger SL, Ede R, et al,. Lack of efficacy of a reduced microparticle diet in a multi-centred trial of patients with active Crohn's disease. Eur J Gastroenterol Hepatol 2005; 17: 377-84.
34. Wright R, Truelove SC,. A controlled therapeutic trial of various diets in ulcerative colitis. Br Med J 1965; 2: 138-41.
35. Suarez FL, Savaiano DA, Levitt MD,. A comparison of symptoms after the consumption of milk or lactose hydrolysed milk by people with self-reported severe lactose intolerance. N Engl J Med 1995; 333: 1-4.
36. Riordan AM, Hunter JO, Cowan RE, et al,. Treatment of active Crohn's disease by exclusion diet: East Anglian multi-centre controlled trial. Lancet 1993; 342: 1131-4.
37. Armitage EL, Aldhous MC, Anderson N, et al,. Incidence of juvenile-onset Crohn's disease in Scotland: association with northern latitude and affluence. Gastroenterology 2004; 127: 1051-7.
38. Nnoaham KE, Clarke A,. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol 2008; 37: 113-9.
39. Garg M, Lubel JS, Sparrow MP, Holt SG, Gibson PR,. Review article: vitamin D and inflammatory bowel disease-established concepts and future directions. Aliment Pharmacol Ther 2012; 36: 324-44.
40. Suibhne TN, Cox G, Healy M, O'Morain C, O'Sullivan M,. Vitamin D deficiency in Crohn's disease: prevalence, risk factors and supplement use in an outpatient setting. J Crohns Colitis 2012; 6: 182-8.
41. Waldron JL, Ashby HL, Cornes MP, et al,. Vitamin D: a negative acute phase reactant. J Clin Pathol 2013; 66: 620-2.
42. Ananthakrishnan AN, Khalili H, Higuchi LM, et al,. Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. Gastroenterology 2012; 142: 482-9.
43. Jorgensen SP, Agnholt J, Glerup H, et al,. Clinical trial: vitamin D3 treatment in Crohn's disease-a randomised double-blind placebo-controlled study. Aliment Pharmacol Ther 2010; 32: 377-83.
44. Marshall J, Narula N,. Management of inflammatory bowel disease with vitamin D: beyond bone health. J Crohns Colitis 2012; 6: 397-404.
45. Bernstein CN, Blanchard JF, Leslie W, Wajda A, Yu BN,. The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study. Ann Intern Med 2000; 133: 795-9.
46. Lewis NR, Scott BB,. Guidelines for osteoporosis in inflammatory bowel disease and coeliac disease 2007. British Society of Gastroenterology. Available at: http://www.bsg.org.uk/clinical-guidelines/ibd/guidelines-for-osteoporosis- in-inflammatory-bowel-disease-and-coeliac-disease.html. Accessed May 28, 2013.
47. Bolland MJ, Avenell A, Baron JA, et al,. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. Br Med J 2010; 341: c3691.
48. Zhu H, Li YR,. Oxidative stress and redox signaling mechanisms of inflammatory bowel disease: updated experimental and clinical evidence. Exp Biol Med (Maywood) 2012; 237: 474-80.
49. Mikirova N, Casciari J, Rogers A, Taylor P,. Effect of high-dose intravenous vitamin C on inflammation in cancer patients. J Transl Med 2012; 10: 189.
50. Aghdassi E, Wendland BE, Steinhart AH, Wolman SL, Jeejeebhoy K, Allard JP,. Antioxidant vitamin supplementation in Crohn's disease decreases oxidative stress: a randomized controlled trial. Am J Gastroenterol 2003; 98: 348-53.
51. Hedin C, Whelan K, Lindsay JO,. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials. Proc Nutr Soc 2007; 66: 307-15.
52. Gibson GR, Roberfroid MB,. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 1995; 125: 1401-12.
53. Lindsay JO, Whelan K, Stagg AJ, et al,. Clinical, microbiological and immunological effect of fructo-oligosaccharide in patients with Crohn's disease. Gut 2006; 55: 348-55.
54. Benjamen JL, Hedin CR, Koutsoumpas A, et al,. Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease. Gut 2011; 60: 923-9.
55. Fujimori S, Gudis K, Mitsui K, et al,. A randomized controlled trial on the efficacy of synbiotic versus probiotic or prebiotic treatment to improve the quality of life in patients with ulcerative colitis. Nutrition 2009; 25: 520-5.
56. Hafer A, Krämer S, Duncker S, Krüger M, Manns MP, Bischoff SC,. Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study. BMC Gastroenterol 2007; 7: 36.
57. Gibson PR, Shepherd SJ,. Evidence-based dietary management of functional gastrointestinal symptoms: the FODMAP approach. J Gastroenterol Hepatol 2010; 25: 252-8.
58. Gearry RB, Irving PM, Barrett JS, Nathan DM, Shepherd SJ, Gibson PR,. Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease-a pilot study. J Crohns Colitis 2009; 3: 8-14.
59. Yao T, Matsui T, Hiwatashi N,. Crohn's disease in Japan: diagnostic criteria and epidemiology. Dis Colon Rectum 2000; 43: S85-93.
60. Asakura K, Nishiwaki Y, Inoue N, Hibi T, Watanabe M, Takebayashi T,. Prevalence of ulcerative colitis and Crohn's disease in Japan. J Gastroenterol 2009; 44: 659-65.
61. Shoda R, Matsueda K, Yamato S, Umeda N,. Epidemiologic analysis of Crohn's disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn's disease in Japan. Am J ClinNutr 1996; 63: 741-5.
62. Epidemiology Group of the Research Committee of Inflammatory Bowel Disease in Japan. Dietary and other risk factors of ulcerative colitis. A case-control study in Japan. J Clin Gastroenterol 1994; 19: 166-71.
63. Maconi G, Ardizzone S, Cucino C, Bezzio C, Russo AG, Bianchi Porro G,. Pre-illness changes in dietary habits and diet as a risk factor for inflammatory bowel disease: a case-control study. World J Gastroenterol 2010; 16: 4297-304.
64. Hou JK, Abraham B, El-Serag H,. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol 2011; 106: 563-73.
65. Spehlmann ME, Begun AZ, Saroglou E, et al,. Risk factors in German twins with inflammatory bowel disease: results of a questionnaire-based survey. J Crohns Colitis 2012; 6: 29-42.
66. Hart AR, Luben R, Olsen A, et al,. Diet in the aetiology of ulcerative colitis: a European prospective cohort study. Digestion 2008; 77: 57-64.
67. IBD in EPIC Study Investigators, Tjonneland A, Overvad K, et al,. Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: a nested case-control study within a European prospective cohort study. Gut 2009; 58: 1606-11.
68. Jantchou P, Morois S, Clavel-Chapelon F, Boutron-Ruault MC, Carbonnel F,. Animal protein intake and risk of inflammatory bowel disease: the E3N prospective study. Am J Gastroenterol 2010; 105: 2195-201.
69. Jowett SL, Seal CJ, Pearce MS, et al,. Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study. Gut 2004; 53: 1479-84.
70. van der Logt EM, Blokzijl T, van der Meer R, Faber KN, Dijkstra G,. Westernized high-fat diet accelerates weight loss in dextran sulfate sodium-induced colitis in mice, which is further aggravated by supplementation of heme. J Nutr Biochem 2012; 24: 1159-65.
71. Dimitrijevic D, Shaw AJ, Florence AT,. Effects of some non-ionic surfactants on transepithelial permeability in Caco-2 cells. J Pharm Pharmacol 2000; 52: 157-62.
72. Roberts CL, Keita AV, Duncan SH, et al,. Translocation of Crohn's disease E. coli across M-cells: contrasting effects of soluble plant fibres and emulsifiers. Gut 2010; 59: 1331-9.
73. Roberts CL, Rushworth SL, Richman E, Rhodes JM,. Hypothesis: increased consumption of emulsifiers as an explanation for the rising incidence of Crohn's disease. J Crohns Colitis 2013; 7: 338-41.
74. Stremmel W, Hanemann A, Ehehalt R, Karner M, Braun A,. Phosphatidylcholine (lecithin) and the mucus layer: evidence of therapeutic efficacy in ulcerative colitis? Dig Dis 2010; 28: 490-6.
75. Tang WH, Wang Z, Levison BS, et al,. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med 2013; 368: 1575-84.
76. Viladomiu M, Hontecillas R, Yuan L, Lu P, Bassaganya-Riera J,. Nutritional protective mechanisms against gut inflammation. J Nutr Biochem 2013; 24: 929-39.
77. Flanagan P, Campbell BJ, Rhodes JM,. Bacteria in the pathogenesis of inflammatory bowel disease. Biochem Soc Trans 2011; 39: 1067-72.
78. Roberts CL, Keita AV, Parsons BN, et al,. Soluble plantain fibre blocks adhesion and M-cell translocation of intestinal pathogens. J Nutr Biochem 2013; 24: 97-103.
79. Rabbani GH, Teka T, Zaman B, Majid N, Khatun M, Fuchs GJ,. Clinical studies in persistent diarrhea: dietary management with green banana or pectin in Bangladeshi children. Gastroenterology 2001; 121: 554-60.
80. Jeffery IB, Claesson MJ, O'Toole PW, et al,. Categorization of the gut microbiota: enterotypes or gradients? Nat Rev Microbiol 2012; 10: 591-2.
81. Wu GD, Chen J, Hoffmann C, et al,. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011; 334: 105-8.
82. De Filippo C, Cavalieri D, Di Paola M, et al,. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A 2010; 107: 14691-6.
83. Muegge BD, Kuczynski J, Knights D, et al,. Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans. Science 2011; 332: 970-4.
84. -/- mice. Nature 2012; 487: 104-8.
85. Leach ST, Mitchell HM, Eng WR, Zhang L, Day AS,. Sustained modulation of intestinal bacteria by exclusive enteral nutrition used to treat children with Crohn's disease. Aliment Pharmacol Ther 2008; 28: 724-33.
86. Lionetti P, Callegari ML, Ferrari S, et al,. Enteral nutrition and microflora in pediatric Crohn's disease. J Parent Ent Nutr 2005; 29: S173-8.
87. Shiga H, Kajiura T, Shinozaki J, et al,. Changes of faecal microbiota in patients with Crohn's disease treated with an elemental diet and total parenteral nutrition. Dig Liver Dis 2012; 44: 736-42.
88. Benus RF, van der Werf TS, Welling GW, et al,. Association between Faecalibacterium prausnitzii and dietary fibre in colonic fermentation in healthy human subjects. Br J Nutr 2010; 104: 693-700.
89. D'Argenio V, Precone V, Casaburi G, et al,. An altered gut microbiome profile in a child affected by Crohn's disease normalized after nutritional therapy. Am J Gastroenterol 2013; 108: 851-2.
90. Piberger H, Oehme A, Hofmann C, et al,. Bilberries and their anthocyanins ameliorate experimental colitis. Mol Nutr Food Res 2011; 55: 1724-9.
91. Song YA, Park YL, Kim KY, et al,. Black tea extract prevents lipopolysaccharide-induced NF-κB signaling and attenuates dextran sulfate sodium-induced experimental colitis. BMC Complement Altern Med 2011; 11: 91.
92. Sugimoto K, Hanai H, Tozawa K, et al,. Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice. Gastroenterology 2002; 123: 1912-22.
93. Hanai H, Sugimoto K,. Curcumin has bright prospects for the treatment of inflammatory bowel disease. Curr Pharm Des 2009; 15: 2087-94.
94. Sánchez-Fidalgo S, Cárdeno A, Sánchez-Hidalgo M, et al,. Dietary unsaponifiable fraction from extra virgin olive oil supplementation attenuates acute ulcerative colitis in mice. Eur J Pharm Sci 2012; 48: 572-81.
95. Sánchez-Fidalgo S, Cárdeno A, Sánchez-Hidalgo M, Aparicio-Soto M, de la Lastra CA,. Dietary extra virgin olive oil polyphenols supplementation modulates DSS-induced chronic colitis in mice. J Nutr Biochem 2013; 24: 1401-13.
96. Brown AC, Rampertab SD, Mullin GE,. Existing dietary guidelines for Crohn's disease and ulcerative colitis. Expert Rev Gastroenterol Hepatol 2011; 5: 411-25.
97. Yamamoto T, Nakahigashi M, Saniabadi AR, et al,. Impacts of long-term enteral nutrition on clinical and endoscopic disease activities and mucosal cytokines during remission in patients with Crohn's disease: a prospective study. Inflamm Bowel Dis 2007; 13: 1493-501.
98. Yamamoto T, Shiraki M, Nakahigashi M, Umegae S, Matsumoto K,. Enteral nutrition to suppress postoperative Crohn's disease recurrence: a five-year prospective cohort study. Int J Colorectal Dis 2013; 28: 335-40.
99. Turner D, Zlotkin SH, Shah PS, Griffiths AM,. Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev 2009; 1: CD006320.
100. Grogan JL, Casson DH, Terry A, Burdge GC, El-Matary W, Dalzell AM,. Enteral feeding therapy for newly diagnosed pediatric Crohn's disease: a double-blind randomized controlled trial with two years follow-up. Inflamm Bowel Dis 2012; 18: 246-53.
101. Turner D, Steinhart AH, Griffiths AM,. Omega 3 fatty acids (fish oil) for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 2007; 3: CD006443.